Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 456

1.

In reply to: Confirmation of antibodies against hepatitis C virus by recombinant immunoblot: Is it really an improvement to abandon it?

García F, Aguilera A, Crespo J, Pineda JA.

Enferm Infecc Microbiol Clin. 2019 Aug 2. pii: S0213-005X(19)30200-9. doi: 10.1016/j.eimc.2019.07.001. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
31383373
2.

Inadequate oxygen delivery index dose is associated with cardiac arrest risk in neonates following cardiopulmonary bypass surgery.

Futterman C, Salvin JW, McManus M, Lowry AW, Baronov D, Almodovar MC, Pineda JA, Nadkarni VM, Laussen PC, Gazit AZ.

Resuscitation. 2019 Jul 17;142:74-80. doi: 10.1016/j.resuscitation.2019.07.013. [Epub ahead of print]

PMID:
31325555
3.

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1.

Eron JJ, Orkin C, Cunningham D, Pulido F, Post FA, De Wit S, Lathouwers E, Hufkens V, Jezorwski J, Petrovic R, Brown K, Van Landuyt E, Opsomer M; EMERALD study group.

Antiviral Res. 2019 Jul 4;170:104543. doi: 10.1016/j.antiviral.2019.104543. [Epub ahead of print]

4.

Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection.

Real LM, Macías J, Rivero-Juárez A, Téllez F, Merino D, Moreno-Grau S, Orellana A, Gómez-Salgado J, Sáez ME, Frías M, Corma-Gómez A, Merchante N, Ruiz A, Caruz A, Pineda JA; GEHEP 012 study group.

Sci Rep. 2019 Jun 21;9(1):9054. doi: 10.1038/s41598-019-45389-4.

5.

MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection.

Brochado-Kith Ó, Gómez Sanz A, Real LM, Crespo García J, Ryan Murúa P, Macías J, Cabezas González J, Troya J, Pineda JA, Arias Loste MT, Díez Viñas V, Jiménez-Sousa MÁ, Medrano de Dios LM, Cuesta De la Plaza I, Monzón Fernández S, Resino García S, Fernández-Rodríguez A.

J Clin Med. 2019 Jun 14;8(6). pii: E849. doi: 10.3390/jcm8060849.

6.

A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study).

Real LM, Fernández-Fuertes M, Sáez ME, Rivero-Juárez A, Frías M, Téllez F, Santos J, Merino D, Moreno-Grau S, Gómez-Salgado J, González-Serna A, Corma-Gómez A, Ruiz A, Macías J, Pineda JA.

Liver Int. 2019 Jun 17. doi: 10.1111/liv.14177. [Epub ahead of print]

PMID:
31206233
7.

The association of early post-resuscitation hypotension with discharge survival following targeted temperature management for pediatric in-hospital cardiac arrest.

Topjian AA, Telford R, Holubkov R, Nadkarni VM, Berg RA, Dean JM, Moler FW; Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) Trial Investigators.

Resuscitation. 2019 Aug;141:24-34. doi: 10.1016/j.resuscitation.2019.05.032. Epub 2019 Jun 5.

PMID:
31175965
8.

10Kin1day: A Bottom-Up Neuroimaging Initiative.

van den Heuvel MP, Scholtens LH, van der Burgh HK, Agosta F, Alloza C, Arango C, Auyeung B, Baron-Cohen S, Basaia S, Benders MJNL, Beyer F, Booij L, Braun KPJ, Filho GB, Cahn W, Cannon DM, Chaim-Avancini TM, Chan SSM, Chen EYH, Crespo-Facorro B, Crone EA, Dannlowski U, de Zwarte SMC, Dietsche B, Donohoe G, Plessis SD, Durston S, Díaz-Caneja CM, Díaz-Zuluaga AM, Emsley R, Filippi M, Frodl T, Gorges M, Graff B, Grotegerd D, Gąsecki D, Hall JM, Holleran L, Holt R, Hopman HJ, Jansen A, Janssen J, Jodzio K, Jäncke L, Kaleda VG, Kassubek J, Masouleh SK, Kircher T, Koevoets MGJC, Kostic VS, Krug A, Lawrie SM, Lebedeva IS, Lee EHM, Lett TA, Lewis SJG, Liem F, Lombardo MV, Lopez-Jaramillo C, Margulies DS, Markett S, Marques P, Martínez-Zalacaín I, McDonald C, McIntosh AM, McPhilemy G, Meinert SL, Menchón JM, Montag C, Moreira PS, Morgado P, Mothersill DO, Mérillat S, Müller HP, Nabulsi L, Najt P, Narkiewicz K, Naumczyk P, Oranje B, Ortiz-Garcia de la Foz V, Peper JS, Pineda JA, Rasser PE, Redlich R, Repple J, Reuter M, Rosa PGP, Ruigrok ANV, Sabisz A, Schall U, Seedat S, Serpa MH, Skouras S, Soriano-Mas C, Sousa N, Szurowska E, Tomyshev AS, Tordesillas-Gutierrez D, Valk SL, van den Berg LH, van Erp TGM, van Haren NEM, van Leeuwen JMC, Villringer A, Vinkers CH, Vollmar C, Waller L, Walter H, Whalley HC, Witkowska M, Witte AV, Zanetti MV, Zhang R, de Lange SC.

Front Neurol. 2019 May 9;10:425. doi: 10.3389/fneur.2019.00425. eCollection 2019.

9.

Genetic associations of the vitamin D and antiviral pathways with natural resistance to HIV-1 infection are influenced by interpopulation variability.

Aguilar-Jimenez W, Zapata W, Rivero-Juárez A, Pineda JA, Laplana M, Taborda NA, Biasin M, Clerici M, Caruz A, Fibla J, Rugeles MT.

Infect Genet Evol. 2019 May 16;73:276-286. doi: 10.1016/j.meegid.2019.05.014. [Epub ahead of print]

PMID:
31103723
10.

Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks.

Corma-Gómez A, Macías J, Merino Muñoz D, Téllez F, Granados R, Morano LE, De Los Santos Gil I, Vera-Méndez FJ, Collado A, Palacios R, Pineda JA.

J Infect. 2019 Jul;79(1):30-35. doi: 10.1016/j.jinf.2019.05.005. Epub 2019 May 14.

PMID:
31100364
11.

Increasing importance of European lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain.

Pérez AB, Vrancken B, Chueca N, Aguilera A, Reina G, García-Del Toro M, Vera F, Von Wichman MA, Arenas JI, Téllez F, Pineda JA, Omar M, Bernal E, Rivero-Juárez A, Fernández-Fuertes E, de la Iglesia A, Pascasio JM, Lemey P, Garcia F, Cuypers L.

Euro Surveill. 2019 Feb;24(9). doi: 10.2807/1560-7917.ES.2019.24.9.1800227.

12.

Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy.

Macías J, Morano LE, Téllez F, Granados R, Rivero-Juárez A, Palacios R, Ríos M, Merino D, Pérez-Pérez M, Collado A, Figueruela B, Morano A, Freyre-Carrillo C, Martín JM, Rivero A, García F, Pineda JA; HEPAVIR group from the Sociedad Andaluza de Enfermedades Infecciosas (SAEI) and the GEHEP group from the Sociedad Española de Enfermedades Infecciosas y Microbiología (SEIMC).

J Hepatol. 2019 Jul;71(1):45-51. doi: 10.1016/j.jhep.2019.02.018. Epub 2019 Mar 8.

PMID:
30853642
13.

HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals.

Corma-Gómez A, Morano L, Téllez F, Rivero-Juárez A, Real LM, Alados JC, Ríos-Villegas MJ, Vera-Méndez FJ, Muñoz RP, Geijo P, Macías J, Pineda JA; RIS-HEP13 and GEHEP 011 study groups.

AIDS. 2019 Jun 1;33(7):1167-1174. doi: 10.1097/QAD.0000000000002186.

PMID:
30845068
14.

Hepatitis C virus infection in Spain: Challenges in the track to elimination.

Corma-Gómez A, Pineda JA.

Enferm Infecc Microbiol Clin. 2019 Apr;37(4):219-221. doi: 10.1016/j.eimc.2019.01.004. Epub 2019 Feb 14. English, Spanish. No abstract available.

PMID:
30772101
15.

Pediatric Neurocritical Care: Off to a Good Start.

Pineda JA, Limbrick DD.

Pediatr Crit Care Med. 2019 Jan;20(1):97-98. doi: 10.1097/PCC.0000000000001771. No abstract available.

PMID:
30614985
16.

North American survey on the post-neuroimaging management of children with mild head injuries.

Greenberg JK, Jeffe DB, Carpenter CR, Yan Y, Pineda JA, Lumba-Brown A, Keller MS, Berger D, Bollo RJ, Ravindra VM, Naftel RP, Dewan MC, Shah MN, Burns EC, O'Neill BR, Hankinson TC, Whitehead WE, Adelson PD, Tamber MS, McDonald PJ, Ahn ES, Titsworth W, West AN, Brownson RC, Limbrick DD.

J Neurosurg Pediatr. 2018 Oct 26;23(2):227-235. doi: 10.3171/2018.7.PEDS18263.

PMID:
30485194
17.

Outcomes of children with severe traumatic brain injury.

Pineda JA.

Lancet Child Adolesc Health. 2019 Jan;3(1):3-4. doi: 10.1016/S2352-4642(18)30373-0. Epub 2018 Nov 23. No abstract available.

PMID:
30473438
18.

Extracorporeal Cardiopulmonary Resuscitation: One-Year Survival and Neurobehavioral Outcome Among Infants and Children With In-Hospital Cardiac Arrest.

Meert KL, Guerguerian AM, Barbaro R, Slomine BS, Christensen JR, Berger J, Topjian A, Bembea M, Tabbutt S, Fink EL, Schwartz SM, Nadkarni VM, Telford R, Dean JM, Moler FW; Therapeutic Hypothermia After Pediatric Cardiac Arrest (THAPCA) Trial Investigators.

Crit Care Med. 2019 Mar;47(3):393-402. doi: 10.1097/CCM.0000000000003545.

PMID:
30422861
19.

Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users.

Pineda JA, Climent B, García F, García Deltoro M, Granados R, Gómez F, Macías J, Mena Á, Merchante N, Ochoa E, Roncero C, Ruiz JJ, Téllez F, Morano L.

Enferm Infecc Microbiol Clin. 2018 Nov 8. pii: S0213-005X(18)30266-0. doi: 10.1016/j.eimc.2018.09.006. [Epub ahead of print] English, Spanish.

PMID:
30415884
20.

Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients.

Merchante N, Figueruela B, Rodríguez-Fernández M, Rodríguez-Arrondo F, Revollo B, Ibarra S, Galindo MJ, Merino E, Montero M, Téllez F, García-Deltoro M, Rivero-Juárez A, Delgado-Fernández M, Ríos-Villegas MJ, Aguirrebengoa K, García MA, Portu J, Vera-Méndez FJ, Villalobos M, Mínguez C, De Los Santos I, López-Ruz MA, Omar M, Galera C, Macias J, Pineda JA; GEHEP-002 Study Group.

AIDS. 2019 Feb 1;33(2):269-278. doi: 10.1097/QAD.0000000000002065.

PMID:
30325782
21.

Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life.

Real LM, Macías J, Pérez AB, Merino D, Granados R, Morano L, Delgado M, Ríos MJ, Galera C, Deltoro MG, Merchante N, García F, Pineda JA.

Sci Rep. 2018 Oct 8;8(1):14905. doi: 10.1038/s41598-018-33367-1.

22.

Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH).

Calleja JL, Macias J, Forns X, Garcia F, Berenguer M, Garcia Deltoro M, Buti M, Granados R, Carrion JA, Morano L, Fernandez I, Coste P, Pineda JA.

Gastroenterol Hepatol. 2018 Nov;41(9):597-608. doi: 10.1016/j.gastrohep.2018.07.010. Epub 2018 Sep 27. English, Spanish. No abstract available.

PMID:
30270150
23.

Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients.

Macías J, Téllez F, Rivero-Juárez A, Palacios R, Morano LE, Merino D, Collado A, García-Fraile L, Omar M, Pineda JA; the HEPAVIR, GEHEP and RIS-HEP07 study groups.

J Viral Hepat. 2019 Jan;26(1):48-54. doi: 10.1111/jvh.13003. Epub 2018 Oct 17.

PMID:
30199593
24.

Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection.

Macías J, Granados R, Téllez F, Merino D, Pérez M, Morano LE, Palacios R, Paniagua M, Frías M, Merchante N, Pineda JA; HEPAVIR GEHEP, RIS-HEP07 study groups.

J Viral Hepat. 2019 Jan;26(1):16-24. doi: 10.1111/jvh.12990. Epub 2018 Sep 27.

PMID:
30141222
25.

Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

Rivero-Juárez A, Aguilera A, Avellón A, García-Deltoro M, García F, Gortazar C, Granados R, Macías J, Merchante N, Oteo JA, Pérez-Gracia MT, Pineda JA, Rivero A, Rodriguez-Lazaro D, Téllez F, Morano-Amado LE; Grupo redactor de GeHEP SEIMC.

Enferm Infecc Microbiol Clin. 2018 Jul 30. pii: S0213-005X(18)30227-1. doi: 10.1016/j.eimc.2018.06.014. [Epub ahead of print] English, Spanish.

PMID:
30072282
26.

Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis.

Cuypers L, Pérez AB, Chueca N, Aldamiz-Echevarría T, Alados JC, Martínez-Sapiña AM, Merino D, Pineda JA, Téllez F, Espinosa N, Salméron J, Rivero-Juarez A, Vivancos MJ, Hontañón V, Vandamme AM, García F.

PLoS One. 2018 Jul 25;13(7):e0201268. doi: 10.1371/journal.pone.0201268. eCollection 2018.

27.

Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis.

Merchante N, Rivero-Juárez A, Téllez F, Merino D, Ríos-Villegas MJ, Villalobos M, Omar M, Rincón P, Rivero A, Pérez-Pérez M, Raffo M, López-Montesinos I, Palacios R, Gómez-Vidal MA, Macías J, Pineda JA; Members of the HEPAVIR-Cirrhosis Study Group .

J Antimicrob Chemother. 2018 Sep 1;73(9):2435-2443. doi: 10.1093/jac/dky234.

PMID:
29982683
28.

Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis.

Esteban R, Pineda JA, Calleja JL, Casado M, Rodríguez M, Turnes J, Morano Amado LE, Morillas RM, Forns X, Pascasio Acevedo JM, Andrade RJ, Rivero A, Carrión JA, Lens S, Riveiro-Barciela M, McNabb B, Zhang G, Camus G, Stamm LM, Brainard DM, Subramanian GM, Buti M.

Gastroenterology. 2018 Oct;155(4):1120-1127.e4. doi: 10.1053/j.gastro.2018.06.042. Epub 2018 Jun 27.

PMID:
29958855
29.

Development of the CIDSS2 Score for Children with Mild Head Trauma without Intracranial Injury.

Greenberg JK, Yan Y, Carpenter CR, Lumba-Brown A, Keller MS, Pineda JA, Brownson RC, Limbrick DD.

J Neurotrauma. 2018 Nov 15;35(22):2699-2707. doi: 10.1089/neu.2017.5324. Epub 2018 Aug 29.

PMID:
29882466
30.

Improving the performance of virtual crossmatch results by correlating with nationally-performed physical crossmatches: Obtaining additional value from proficiency testing activities.

Wrenn SM, Marroquin CE, Hain DS, Harm SK, Pineda JA, Hammond PB, Shah DH, Hillyard SE, Fung MK.

Hum Immunol. 2018 Aug;79(8):602-609. doi: 10.1016/j.humimm.2018.05.009. Epub 2018 Jun 1.

PMID:
29864460
31.

Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients.

Merchante N, Rodríguez-Arrondo F, Revollo B, Merino E, Ibarra S, Galindo MJ, Montero M, García-Deltoro M, Rivero-Juárez A, Téllez F, Delgado-Fernández M, Ríos-Villegas MJ, García MA, Vera-Méndez FJ, Ojeda-Burgos G, López-Ruz MA, Metola L, Omar M, Alemán-Valls MR, Aguirrebengoa K, Portu J, Raffo M, Macías J, Pineda JA; GEHEP-002 Study Group.

AIDS. 2018 Jul 17;32(11):1423-1430. doi: 10.1097/QAD.0000000000001809.

PMID:
29596108
32.

Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice.

Pineda JA, Rivero-Juárez A, de Los Santos I, Collado A, Merino D, Morano-Amado LE, Ríos MJ, Pérez-Pérez M, Téllez F, Palacios R, Pérez AB, Mancebo M, Rivero A, Macías J.

HIV Clin Trials. 2018 Feb;19(1):23-30. doi: 10.1080/15284336.2018.1436637. Epub 2018 Feb 15.

PMID:
29447085
33.

Facilitating Neurofeedback in Children with Autism and Intellectual Impairments Using TAGteach.

LaMarca K, Gevirtz R, Lincoln AJ, Pineda JA.

J Autism Dev Disord. 2018 Jun;48(6):2090-2100. doi: 10.1007/s10803-018-3466-4.

PMID:
29380270
34.

Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort.

Álvarez-Ossorio MJ, Sarmento E Castro R, Granados R, Macías J, Morano-Amado LE, Ríos MJ, Merino D, Álvarez EN, Collado A, Pérez-Pérez M, Téllez F, Martín JM, Méndez J, Pineda JA, Neukam K; HEPAVIR-DAA, GEHEP-MONO, RIS-HEP07 and RIS-HEP13 Study Groups.

J Viral Hepat. 2018 Jun;25(6):699-706. doi: 10.1111/jvh.12867. Epub 2018 Feb 27.

PMID:
29377515
35.

The cost of a pediatric neurocritical care program for traumatic brain injury: a retrospective cohort study.

Howard SW, Zhang Z, Buchanan P, Bernell SL, Williams C, Pearson L, Huetsch M, Gill J, Pineda JA.

BMC Health Serv Res. 2018 Jan 12;18(1):20. doi: 10.1186/s12913-017-2768-0.

36.

Effects of repetitive transcranial magnetic stimulation (rTMS) on attribution of movement to ambiguous stimuli and EEG mu suppression.

Ando' A, Pineda JA, Giromini L, Soghoyan G, QunYang, Bohm M, Maryanovsky D, Zennaro A.

Brain Res. 2018 Feb 1;1680:69-76. doi: 10.1016/j.brainres.2017.12.007. Epub 2017 Dec 13.

PMID:
29247630
37.

Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries.

Leblebicioglu H, Arends JE, Ozaras R, Corti G, Santos L, Boesecke C, Ustianowski A, Duberg AS, Ruta S, Salkic NN, Husa P, Lazarevic I, Pineda JA, Pshenichnaya NY, Tsertswadze T, Matičič M, Puca E, Abuova G, Gervain J, Bayramli R, Ahmeti S, Koulentaki M, Kilani B, Vince A, Negro F, Sunbul M, Salmon D; ESGHV (part of ESCMID).

Antiviral Res. 2018 Feb;150:9-14. doi: 10.1016/j.antiviral.2017.12.001. Epub 2017 Dec 5.

PMID:
29217468
38.

Impact of Ethylene Glycol Toxicity on Donor Organ Viability: A Case Report.

Mendelson NL, Fitzgerald A, Kumar A, Pineda JA, MacDougall J, Solomon RJ, Gibson PC, Prikis M, Marroquin CE.

Transplant Proc. 2017 Dec;49(10):2411-2414. doi: 10.1016/j.transproceed.2017.09.004.

PMID:
29198693
39.

Brain metabolism and severe pediatric traumatic brain injury.

Griffiths H, Goyal MS, Pineda JA.

Childs Nerv Syst. 2017 Oct;33(10):1719-1726. doi: 10.1007/s00381-017-3514-y. Epub 2017 Sep 6. Review.

PMID:
29149384
40.

Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial.

Orkin C, Molina JM, Negredo E, Arribas JR, Gathe J, Eron JJ, Van Landuyt E, Lathouwers E, Hufkens V, Petrovic R, Vanveggel S, Opsomer M; EMERALD study group.

Lancet HIV. 2018 Jan;5(1):e23-e34. doi: 10.1016/S2352-3018(17)30179-0. Epub 2017 Oct 6.

PMID:
28993180
41.

Increased risk organ transplantation in the pediatric population.

Wrenn SM, Callas PW, Kapoor T, Aunchman AF, Paine AN, Pineda JA, Marroquin CE.

Pediatr Transplant. 2017 Dec;21(8). doi: 10.1111/petr.13041. Epub 2017 Sep 17.

PMID:
28921748
42.

Emergency Neurological Life Support: Acute Non-traumatic Weakness.

Caulfield AF, Flower O, Pineda JA, Uddin S.

Neurocrit Care. 2017 Sep;27(Suppl 1):29-50. doi: 10.1007/s12028-017-0450-3.

PMID:
28916943
43.

Human Movement Responses to the Rorschach and Mirroring Activity: An fMRI Study.

Giromini L, Viglione DJ Jr, Pineda JA, Porcelli P, Hubbard D, Zennaro A, Cauda F.

Assessment. 2019 Jan;26(1):56-69. doi: 10.1177/1073191117731813. Epub 2017 Sep 14.

44.

Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.

Macías J, Mancebo M, Merino D, Téllez F, Montes-Ramírez ML, Pulido F, Rivero-Juárez A, Raffo M, Pérez-Pérez M, Merchante N, Cotarelo M, Pineda JA; Spanish AIDS Research Network-HEP09 Study Group.

Clin Infect Dis. 2017 Sep 15;65(6):1012-1019. doi: 10.1093/cid/cix467.

PMID:
28903510
45.

Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients.

Merchante N, Aldámiz-Echevarría T, García-Álvarez M, Rivero-Juárez A, Macías J, Miralles P, Jiménez-Sousa MA, Mancebo M, Pérez-Latorre L, Pineda-Tenor D, Berenguer J, Resino S, Pineda JA.

J Viral Hepat. 2018 Feb;25(2):180-186. doi: 10.1111/jvh.12769. Epub 2017 Sep 7.

PMID:
28783247
46.

Assessing the Effectiveness of Neurofeedback Training in the Context of Clinical and Social Neuroscience.

Orndorff-Plunkett F, Singh F, Aragón OR, Pineda JA.

Brain Sci. 2017 Aug 7;7(8). pii: E95. doi: 10.3390/brainsci7080095. Review.

47.

Identifying Risk for Acute Kidney Injury in Infants and Children Following Cardiac Arrest.

Neumayr TM, Gill J, Fitzgerald JC, Gazit AZ, Pineda JA, Berg RA, Dean JM, Moler FW, Doctor A.

Pediatr Crit Care Med. 2017 Oct;18(10):e446-e454. doi: 10.1097/PCC.0000000000001280.

48.

HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.

Neukam K, Morano-Amado LE, Rivero-Juárez A, Mancebo M, Granados R, Téllez F, Collado A, Ríos MJ, de Los Santos-Gil I, Reus-Bañuls S, Vera-Méndez F, Geijo-Martínez P, Montero-Alonso M, Suárez-Santamaría M, Pineda JA.

HIV Clin Trials. 2017 May;18(3):126-134. doi: 10.1080/15284336.2017.1330801.

PMID:
28599618
49.

Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Asensi V, Crespo M, Domingo P, Iribarren JA, Lázaro P, López-Aldeguer J, Lozano F, Martínez E, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, Santos J, de la Torre J, Tuset M, Gatell JM.

Enferm Infecc Microbiol Clin. 2018 May;36(5):268-276. doi: 10.1016/j.eimc.2017.04.002. Epub 2017 May 19. English, Spanish.

PMID:
28532596
50.

The Road Between Statistics and Clinical Decision Making Is Longer Than We Think.

Pineda JA, Gill J.

Pediatr Crit Care Med. 2017 Apr;18(4):388-390. doi: 10.1097/PCC.0000000000001113. No abstract available.

PMID:
28376007

Supplemental Content

Loading ...
Support Center